Mini Diamonds (India) Ltd. (MINID) — Tipsheet

Mini Diamonds promoters pledge ₹8.88 cr for lab-grown pivot via warrants

Tipsheet Editorial — Thu, 09 Jul 2026 11:15:27 GMT

Upendra and Ronish Shah will buy 1.11 cr convertible warrants at a 30% premium, funding the company's entry into lab-grown diamonds. The EGM is set for August 7.

What’s new

Board approves 1.11 cr convertible warrants at ₹8 each, issuing to promoters Upendra and Ronish Shah
Warrants priced at a 30% premium to market, aggregating ₹8.88 crore or ~6.2% of market cap
Funds earmarked for lab-grown diamond expansion; EGM convened for August 7, 2026

Why it matters

For a nano-cap with a trailing net loss of ₹6 crore, a promoter-backed infusion at a premium signals conviction. The 4.5% dilution is manageable, but execution risk is real. The market now has specific terms for what was previously a vague board intimation.

What we’re watching

Shareholder approval at the August 7 EGM
Initial revenue contribution from the lab-grown diamond business
Any follow-on orders to complement the ₹16.25 cr and ₹14 cr orders from June 2026

The full read

Mini Diamonds' promoters are backing their lab-grown diamond pivot with their own capital. The board approved 1.11 crore convertible warrants at ₹8 each, raising ₹8.88 crore, about 6.2% of market cap. Upendra and Ronish Shah are paying a 30% premium to the market price. That is conviction. The funds will fuel expansion into lab-grown diamonds, which is growing faster than natural stones. But Mini Diamonds is coming off a ₹6 crore net loss in the March quarter on ₹150 crore revenue, so execution matters more than intent. The 4.5% dilution is manageable, and the EGM on August 7 is the next milestone. For a nano-cap with negative trailing profit, a promoter-backed infusion at a premium removes some funding uncertainty and aligns interests with minority holders. The lab-grown push is a significant opportunity, but the company has yet to prove it can turn potential into profit.

Primary source: BSE · NSE

Mini Diamonds to mull preferential issue for lab-grown push

Tipsheet Editorial — Mon, 06 Jul 2026 08:57:19 GMT

The ₹143-cr company will meet on July 9 to propose issuing equity or warrants to promoters, a move that could dilute minority holders to fund synthetic diamond growth.

What’s new

Board meeting on July 9 to consider preferential issue of equity or convertible warrants to promoter group.
Proceeds to be used for expanding lab-grown diamond business.
Subject to shareholder and regulatory approvals.

Why it matters

For a nano-cap with a trailing net loss of ₹6 cr on ₹150 cr quarterly sales, a promoter-led capital raise is a double-edged sword: it signals commitment from insiders but will likely dilute public shareholders significantly. The lack of disclosed terms leaves investors guessing on pricing and dilution.

What we’re watching

Size of the issue and conversion price relative to current market price.
Shareholder approval timeline and promoter stake post-issue.
Any further details on lab-grown diamond capacity plans.

The full read

Mini Diamonds (India) Ltd., a nano-cap with a market cap of ₹143 crore, is heading to the boardroom on July 9 to discuss a preferential issue of equity shares or convertible warrants to its promoter group. The stated aim: fund expansion in lab-grown diamonds, a sector where the company recently landed two orders worth ₹16.25 crore and ₹14 crore. But the numbers tell a cautionary tale. In the March 2026 quarter, sales were ₹150 crore but net profit was a loss of ₹6 crore. A trailing P/E of 134.4 leaves no margin for error. With no deal size or conversion price announced, investors are being asked to approve a blank cheque. The promoters are putting in their own money — that counts for something. But in a company this small, the dilution will be felt by every existing shareholder.

Primary source: BSE · NSE

Mini Diamonds lands ₹16.25 cr order from Aura Diamond

Tipsheet Editorial — Tue, 16 Jun 2026 08:51:09 GMT

The domestic order for cut and polished natural diamonds is ~9.8% of market cap, due in four months with 150-day payment terms.

What’s new

Mini Diamonds secures ₹16.25 crore order from Mumbai-based Aura Diamond.
Order represents ~9.8% of the company's ₹166 crore market cap.
Completion expected within four months; payment due within 150 days.

Why it matters

For a nano-cap with a trailing P/E of 156 and a loss-making latest quarter, this order provides near-term revenue visibility. The natural diamond segment offers selective opportunities, but profitability remains the key test.

What we’re watching

Whether the order translates into positive earnings in the next quarter.
Any further domestic orders from new or repeat clients.
The company's ability to manage payment timelines without straining working capital.

The full read

Mini Diamonds has bagged a ₹16.25 crore domestic order from Mumbai-based Aura Diamond for cut and polished natural diamonds — roughly 9.8% of its ₹166 crore market cap. That's a material win. This follows a ₹14 crore order from Kavish Jewels announced just days ago, and a previous ₹12 crore contract from another client. Both reinforce the company's growing domestic traction in the natural diamond segment. The order comes with a four-month completion timeline and 150-day payment terms. The natural diamond segment, management says, offers selective opportunities for reliable players. But here is the catch: Mini Diamonds reported a ₹6 crore loss on ₹150 crore sales in its latest quarter. Revenue alone is not enough. The open question is whether these orders can generate margins, not just fill capacity.

Primary source: BSE · NSE

Mini Diamonds lands ₹14 cr order from new Mumbai client

Tipsheet Editorial — Mon, 15 Jun 2026 08:54:47 GMT

Order from Kavish Jewels is ~8.5% of the company's ₹165 cr market cap, providing near-term revenue visibility for the nano-cap.

What’s new

Won ₹14 crore order to supply lab-grown diamonds to Mumbai-based Kavish Jewels.
Order expected to complete in four months; payment within 150 days.
Represents approximately 8.5% of the company's ₹165 crore market cap.

Why it matters

For a nano-cap with trailing negative profits, this single order offers meaningful revenue visibility. It also demonstrates progress in expanding domestic client relationships. However, the company's weak profitability and reliance on one-off orders remain risks.

What we’re watching

Timely completion and payment – 150-day terms could strain working capital.
Repeat orders from Kavish Jewels or other new clients.
Impact on revenue and margins in upcoming quarterly results.

The full read

Mini Diamonds has won a ₹14 crore order to supply cut and polished lab-grown diamonds to new Mumbai-based client Kavish Jewels. At roughly 8.5% of its ₹165 crore market cap, the deal is a material win for a nano-cap that reported negative trailing profits despite 54.9% revenue growth. Management sees this as evidence of success in broadening domestic relationships. The order is to be completed within four months, with payment due 150 days later. For a company with a P/E of 155 and an ROE of just 5.3%, every order matters. Yet the real test is repeatability — one client, however welcome, does not fix the profitability picture.

Primary source: BSE · NSE